“…Unfortunately, inappropriate ABU in this sector has contributed to the development of bacterial antimicrobial resistance (AMR) [ 9 , 10 , 11 ]. Bacterial AMR affects the globe negatively and now accounts for appreciable challenges in treating human infections, food security, and the healthcare system [ 12 , 13 , 14 , 15 ], leading to increased morbidity and mortality across countries [ 16 , 17 ]. Overall, there were an estimated 4.95 million deaths globally in 2019 associated with bacterial AMR, the greatest in sub-Saharan Africa, which, if unchecked, will reduce the income of countries by up to USD 3.4 trillion by 2030, equivalent to 3.8% of annual gross domestic product [ 17 , 18 , 19 ].…”